António Torres

3.6k total citations
48 papers, 2.0k citations indexed

About

António Torres is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, António Torres has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Hematology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in António Torres's work include Epigenetics and DNA Methylation (18 papers), Cancer-related gene regulation (13 papers) and Acute Myeloid Leukemia Research (11 papers). António Torres is often cited by papers focused on Epigenetics and DNA Methylation (18 papers), Cancer-related gene regulation (13 papers) and Acute Myeloid Leukemia Research (11 papers). António Torres collaborates with scholars based in Spain, United Kingdom and United States. António Torres's co-authors include José Román‐Gómez, Anabel Heiniger, Xabier Agirre, Felipe Prósper, Antonio Jiménez‐Velasco, Leire Gárate, Edurne San José‐Eneriz, Lucía Cordeu, Juan A. Castillejo and Marı́a José Calasanz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

António Torres

48 papers receiving 2.0k citations

Peers

António Torres
Sébastien Malinge United States
S. Tiong Ong United States
Andrew G. Muntean United States
F Viguié France
Miranda Buitenhuis Netherlands
António Torres
Citations per year, relative to António Torres António Torres (= 1×) peers José Román‐Gómez

Countries citing papers authored by António Torres

Since Specialization
Citations

This map shows the geographic impact of António Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by António Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites António Torres more than expected).

Fields of papers citing papers by António Torres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by António Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by António Torres. The network helps show where António Torres may publish in the future.

Co-authorship network of co-authors of António Torres

This figure shows the co-authorship network connecting the top 25 collaborators of António Torres. A scholar is included among the top collaborators of António Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with António Torres. António Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torres, António, et al.. (2020). Tratamento artroscópico da doença de Freiberg – Relato de caso. Revista Brasileira de Ortopedia. 57(5). 891–895. 1 indexed citations
3.
Rodríguez‐Otero, Paula, José Román‐Gómez, Amaia Vilas‐Zornoza, et al.. (2011). Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. British Journal of Haematology. 155(1). 73–83. 47 indexed citations
4.
Martínez, Rodríguez, et al.. (2010). microRNA Methylation Profile Has Prognosis Impact in Acute Lymphoblastic Leukemia Patients Undergoing Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(5). 745–748. 3 indexed citations
5.
Agirre, Xabier, Amaia Vilas‐Zornoza, Antonio Jiménez‐Velasco, et al.. (2009). Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia. Cancer Research. 69(10). 4443–4453. 242 indexed citations
6.
Barbarroja, Nuria, M. Luque, Laura M. López‐Sánchez, et al.. (2009). Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia. Experimental Hematology. 37(6). 679–691. 9 indexed citations
7.
José‐Eneriz, Edurne San, Xabier Agirre, Antonio Jiménez‐Velasco, et al.. (2009). Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. European Journal of Cancer. 45(10). 1877–1889. 69 indexed citations
8.
Agirre, Xabier, Antonio Jiménez‐Velasco, Edurne San José‐Eneriz, et al.. (2008). Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth. Molecular Cancer Research. 6(12). 1830–1840. 173 indexed citations
9.
Montiel‐Duarte, Cristina, Lucía Cordeu, Xabier Agirre, et al.. (2008). Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leukemia Research. 32(5). 709–716. 33 indexed citations
10.
Martı́n, Vanesa, Xabier Agirre, Antonio Jiménez‐Velasco, et al.. (2008). Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia‐positive acute lymphoblastic leukemia. Cancer Science. 99(9). 1865–1868. 28 indexed citations
11.
José‐Eneriz, Edurne San, José Román‐Gómez, Lucía Cordeu, et al.. (2008). BCR‐ABL1‐induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. British Journal of Haematology. 142(4). 571–582. 31 indexed citations
12.
Román‐Gómez, José, Antonio Jiménez‐Velasco, Xabier Agirre, et al.. (2007). Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leukemia Research. 31(11). 1521–1528. 52 indexed citations
13.
Barbarroja, Nuria, Vanessa Hernández, Carmen Martín, et al.. (2007). Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia. Leukemia & lymphoma. 48(6). 1187–1199. 9 indexed citations
14.
Román‐Gómez, José, Antonio Jiménez‐Velasco, Lucía Cordeu, et al.. (2007). WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. European Journal of Cancer. 43(18). 2736–2746. 65 indexed citations
15.
Agirre, Xabier, José Román‐Gómez, Iria Vázquez, et al.. (2005). Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer. 118(8). 1945–1953. 76 indexed citations
16.
Agirre, Xabier, José Román‐Gómez, Antonio Jiménez‐Velasco, et al.. (2005). ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene. 25(13). 1862–1870. 56 indexed citations
17.
Sánchez, Joaquín, Concha Herrera, António Torres, José Román‐Gómez, & Miguel A. Álvarez. (2004). Chemotherapy plus G‐CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid linnegCD11cpos dendritic precursor cells. British Journal of Haematology. 124(5). 636–644. 8 indexed citations
18.
Gottardi, Enrico, Daniela De Micheli, Daniela Cilloni, et al.. (2000). Novel type of BCR–ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation. British Journal of Haematology. 111(2). 644–646. 2 indexed citations
19.
Gómez, Pedro, et al.. (2000). An unusual form of persistent polyclonal B lymphocytosis in an infant. British Journal of Haematology. 110(2). 430–433. 4 indexed citations
20.
Serrano, Josefina, Antonio Jiménez, J A Castillejo, et al.. (1999). Genetic, phenotypic and clinical features of acute lymphoblastic leukemias expressing myeloperoxidase mRNA detected by RT-PCR. Leukemia. 13(2). 175–180. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026